A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts

Human Immunology

Volumn 63, Issue 11, 2002, Pages 1019-1025

  Welters, Marij J P ^a   Oei, Frans B S ^a   Witvliet, Marian D ^b   Vaessen, Lenard M B ^a   Cromme Dijkhuis, Adri H ^a   Bogers, A J J C ^a   Weimar, Willem ^a   Claas, Frans H J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibody titers; Cryopreserved human heart valves; Graft failure; HLA antibodies; Transplantation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN;

ADOLESCENT; AGED; ALLOGRAFT; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CRYOPRESERVATION; DONOR; FEMALE; GRAFT FAILURE; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VALVE REPLACEMENT; HISTOCOMPATIBILITY TEST; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; INFANT; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; CHILD; CHILD, PRESCHOOL; CRYOPRESERVATION; FEMALE; HEART VALVES; HLA ANTIGENS; HUMANS; INFANT; ISOANTIBODIES; MALE; MIDDLE AGED; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036829145     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00441-X     Document Type: Article

References (18)

1. O'Brien MF, Stafford EG, Gardner MAH: Allograft aortic valve replacement: Long-term follow-up. Ann Thorac Surg 60:S65, 1995.
2. Baskett RJ, Ross DB, Nanton MA, Murphy DA: Factors in the early failure of cryopreserved homograft pulmonary valves in children: Preserved immunogenicity? J Thorac Cardiovasc Surg 112:1170, 1996.
3. Gerestein CG, Takkenberg JJM, Oei FBS, Cromme-Dijkhuis AH, Spitaels SEC, van Herwerden LA, Steyerberg EW, Bogers AJJC: Right ventricular outflow tract reconstruction with an allograft conduit. Ann Thorac Surg 71:911, 2001.
4. Hogan P, Duplock L, Green M, Smith S, Gall KL, Frazer IH, O'Brien MF: Human aortic valve allografts elicit a donor-specific immune response. J Thorac Cardiovasc Surg 112:1260, 1996.
5. Hoekstra FME, Knoop CY, Vaessen LMB, Wassenaar C, Jutte N, Bogers AJJC, Weimar W: Donor-specific cellular immune response against human cardiac valve allografts. J Thorac Cardiovasc Surg 112:281, 1996.
6. Yankah AC, Muller-Hermelink HK, Muller-Ruchholz W, Bernhard A: Antigenitát allogener herzkleppen. Z Herz Thorax Gefaåchir 6:41, 1992.
7. Hawkins JA, Breinholt JP, Lambert LM, Fuller TC, Profaizer T, McGough EC, Shaddy RE: Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg 119:324, 2000.
8. Hoekstra FME, Witvliet M, Knoop CY, Akkersdijk G, Jutte N, Bogers AJJC, Claas FHJ, Weimar W: Donorspecific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. J Heart Lung Transplant 16:570, 1997.
9. Hoekstra FME, Witvliet M, Knoop CY, Wassenaar C, Bogers AJJC, Weimar W, Claas FHJ: Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg 66:2022, 1998.
10. McKenna RM, Takemoto SK, Terasaki PI: Anti-HLA antibodies after solid organ transplantation. Transplantation 69:319, 2000.
11. Thijsen HJM, Bos E, Konertz W, Van Suijlen RJ, De Bij TMMH: Kryokonservierung humaner spenderherzklappen in der herzklappenbank in Rotterdam. Z Herz Thorax Gefaßchir 6(Suppl 1):49, 1992.
12. van Rood JJ, van Leeuwen A, Ploem J: Simultaneous detection of two cell populations by two color fluorescence and application to the recognition of B cell determinants. Nature 262:795, 1976.
13. Bruning JW, Claas FHJ, Kardol MJ, Naipal AM, Niterink JGS, Parlevliet JH, Tanke HJ: Automated reading of HLA-A, B, C and DR typing and screening. In: Kano K, Mori S, Sugisaki T, Toritu M (eds): Cellular, Molecular and Genetic Approaches to Immunodiagnosis and Immunotherapy. Tokyo: University of Tokyo Press, 1978.
14. Okuno T, Kondelis N: Evaluation of dithiothreitol (DTT) for inactivation of IgM antibodies. J Clin Path 31:1152, 1978.
15. Edmunds Jr LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD: Guidelines for reporting morbidity and mortality after cardiac valvular operations: Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 112:708, 1996.
16. Welters MJP, Oei FBS, Vaessen LMB, Stegmann APA, Bogers AJJC, Weimar W: Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation. Clin Exp Immunol 124:353, 2001.
17. Oei FBS, Welters MJP, Vaessen LMB, Marquet RL, Weimar W, Bogers AJJC: Heart valve dysfunctioning due to cellular rejection in a novel heterotopic transplantation rat model. Transplant Int 13:S528, 2000.
18. Oei FBS, Dor FJMF, Stegman APA, Welters MJP, Vaessen LMB, Marquet RL, Bogers AJJC, Weimar W: Helper T-cell frequencies after implantation of aortic valve allografts in the rats. Transplant Proc 33:640, 2001.